反应 #4140412
相关文献 (1)
openreactiondata ↗doi:10.1039/C8SC04228D
反应条件: temp:0.00; pressure:0.00; stir:
来源 ID: ord-14e8458925c142aebc30cb484fb1ed4c暂无可渲染的结构数据
CCN(CC)CC1CCCCN1产品信息
N,N-二乙基-2-哌啶甲胺(CAS 64168-09-8)的产品身份、结构标识及相关反应资料,供化学中间体检索、研发和采购评估使用。
可能的应用方向
仅供专业研发与工业用途
数据库编号 254287
安全提示
仅供专业研发与工业用途。操作前请依据供应商提供的安全数据表完成风险评估。
合成路线数据
12 条反应 · 12 篇文献
反应条件: temp:0.00; pressure:0.00; stir:
来源 ID: ord-14e8458925c142aebc30cb484fb1ed4c反应条件: temp:0.00; pressure:0.00; stir:
来源 ID: ord-0e991b9ff5d1414f8fa012a5e78294ea反应条件: temp:0.00; pressure:0.00; stir:
来源 ID: ord-027ba2e723e341c38a8d16f2a1b71d94反应条件: temp:0.00; pressure:0.00; stir:
来源 ID: ord-14e8458925c142aebc30cb484fb1ed4c反应条件: temp:0.00; pressure:0.00; stir:
来源 ID: ord-14e8458925c142aebc30cb484fb1ed4c反应条件: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
实验步骤: Prepared analogously to Example (1b) from 5,11-dihydro-11-(prop-2-ynyl)-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one, paraformaldehyde and 2-[(diethylamino)methyl]piperidine in a yield of 28% of theory. Colourless crystals, m.p. 132°-134° C.
来源 ID: ord-abd30d24bc32439e8de700030b57f3b1反应条件: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
实验步骤: 5.6 g (0.0174 mole) of 9-chloro-11-(chloroacetyl)-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one were suspended in 100 ml of anhydrous dioxane and, after addition of 6.0 g (0.035 mol) of 2-[(diethylamino)methyl]piperidine, the mixture was boiled under reflux for 12 hours. under reflux for 12 hours
来源 ID: ord-e9cda7394ebd49fe884ed9a7d8113f63反应条件: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
实验步骤: Prepared in analogy to Example 2 from 11-(chloroacetyl)-5,11-dihydro-8-methyl-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one and 2-[(diethylamino)methyl]piperidine, but using acetonitrile as solvent, in a yield of 54% of theory. M.p. 173-174° C. (diisopropylether).
来源 ID: ord-432754fce64e433a96372f2c16b39923反应条件: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
实验步骤: Prepared in analogy to Example 2 from 11-(chloroacetyl)-5,11-dihydro-8-methyl-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one and 2-[(diethylamino)methyl]piperidine, but using acetonitrile as solvent, in a yield of 54% of theory. M.p. 173-174° C. (diisopropylether).
来源 ID: ord-432754fce64e433a96372f2c16b39923反应条件: temp:50.01; pressure:0.00; stir:; See reaction.notes.procedure_details.
实验步骤: A mixture of 125 g (0.388 mole) of 9-chloro-11-(chloroacetyl)-5,11-dihydro-6H-pyrido[2,3-b][1,4]-benzodiazepin-6-one, 2480 ml of dry dimethyl formamide, 73.0 g (0.429 mole) of D,L-2-[(diethylamino)methyl]piperidine, 60 ml (0.429 mole) of anhydrous triethylamine and 3.0 g of sodium iodide was stirred at an internal temperature of 50° C. for 32 hours and then at room temperature for 15 hours. Insolubles were removed by filtration, and the filtrate was evaporated at the oil pump and at a bath temperature of 45° C. The remaining product was dissolved in 5% hydrochloric acid, and the solution was extracted by shaking twice with 50 ml of dichloromethane each time. The aqueous layer was made alkaline by addition of concentrated potassium carbonate solution, and the liberated base was taken up in dichloromethane, and the solution was treated with 2 g of active charcoal and dried over sodium sulphate. The dark oil remaining after the solvent had been removed by evaporation was purified by column chromatography on 800 g of silica gel (35-70 mesh) using dichloro- methane/methanol/ethyl acetate/cyclohexane/concentrated ammonia 59/7.5/25/7.5/1 (v/v) for elution. The fractions containing the compound which was sought (132 g) were dissolved in dilute aqueous maleic acid solution. The filtered solution was washed four times with 50 ml of ethyl acetate each time, and was then saturated with solid potassium carbonate and exhaustively extracted with dichloromethane. The combined dichloromethane phases were dried over sodium sulphate and evaporated, and 109 g of a partially crystallised oil remained. After recrystallisation twice from 450 ml of acetonitrile each time, using 2 g of active charcoal each time, 63.0 g (36% of theory) of colourless crystals of m.p. 167.5-169° C. were obtained. at room temperature for 15 hours Insolubles were removed by filtration the filtrate was evaporated at the oil pump and at a bath temperature of 45° C The remaining product was dissolved in 5% hydrochloric acid the solution was extracted by shaking twice with 50 ml of dichloromethane each time by addition of concentrated potassium carbonate solution the solution was treated with 2 g of active charcoal dried over sodium sulphate had been removed by evaporation was purified by column chromatography on 800 g of silica gel (35-70 mesh) for elution The fractions containing the compound which were dissolved in dilute aqueous maleic acid solution The filtered solution was washed four times with 50 ml of ethyl acetate each time saturated with solid potassium carbonate and exhaustively extracted with dichloromethane The combined dichloromethane phases were dried over sodium sulphate evaporated After recrystallisation twice from 450 ml of acetonitrile each time were obtained
来源 ID: ord-a0ef6c14af0343479996d495bcd90fa2反应条件: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
实验步骤: The title compound is prepared analogously to Example 2 from 11-(chloroacetyl)-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one and (+)-2-[(diethylamino)methyl]piperidine to give colorless crystals, mp. 210°-211.5° C. (n-propanol/activated charcoal): [α]D20 =-12° (dilute aqueous hydrochloride acid).
来源 ID: ord-92c0027987b8449694fde3dd09e425b0反应条件: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
实验步骤: The title compound is prepared analogously to Example 2 from 11-(chloroacetyl)-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one and (+)-2-[(diethylamino)methyl]piperidine to give colorless crystals, mp. 210°-211.5° C. (n-propanol/activated charcoal): [α]D20 =-12° (dilute aqueous hydrochloride acid).
来源 ID: ord-92c0027987b8449694fde3dd09e425b0PubChem References
以下资料来自该化合物的公开数据库参考记录。
